Abel Hall LLC Acquires 2,280 Shares of UnitedHealth Group Incorporated $UNH

Abel Hall LLC raised its holdings in UnitedHealth Group Incorporated (NYSE:UNH) by 338.8% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 2,953 shares of the healthcare conglomerate’s stock after buying an additional 2,280 shares during the quarter. Abel Hall LLC’s holdings in UnitedHealth Group were worth $921,000 as of its most recent SEC filing.

Other institutional investors also recently modified their holdings of the company. Sax Wealth Advisors LLC boosted its stake in UnitedHealth Group by 7.1% during the second quarter. Sax Wealth Advisors LLC now owns 706 shares of the healthcare conglomerate’s stock worth $220,000 after acquiring an additional 47 shares in the last quarter. Focused Investors LLC boosted its position in shares of UnitedHealth Group by 21.8% during the 2nd quarter. Focused Investors LLC now owns 504,000 shares of the healthcare conglomerate’s stock worth $157,233,000 after purchasing an additional 90,100 shares in the last quarter. Shell Asset Management Co. increased its position in UnitedHealth Group by 19.8% in the 2nd quarter. Shell Asset Management Co. now owns 66,912 shares of the healthcare conglomerate’s stock valued at $20,875,000 after buying an additional 11,036 shares in the last quarter. Tyche Wealth Partners LLC grew its stake in UnitedHealth Group by 8.3% in the second quarter. Tyche Wealth Partners LLC now owns 5,127 shares of the healthcare conglomerate’s stock valued at $1,599,000 after acquiring an additional 394 shares during the period. Finally, KLP Kapitalforvaltning AS raised its position in shares of UnitedHealth Group by 3.2% during the second quarter. KLP Kapitalforvaltning AS now owns 326,335 shares of the healthcare conglomerate’s stock worth $101,807,000 after purchasing an additional 10,100 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

Analyst Upgrades and Downgrades

UNH has been the subject of a number of recent research reports. Baird R W lowered shares of UnitedHealth Group from a “hold” rating to a “strong sell” rating in a research note on Thursday, July 31st. JPMorgan Chase & Co. dropped their price target on shares of UnitedHealth Group from $418.00 to $310.00 and set an “overweight” rating on the stock in a research report on Wednesday, August 6th. Cantor Fitzgerald reaffirmed an “overweight” rating and set a $440.00 target price on shares of UnitedHealth Group in a research report on Tuesday, August 26th. Weiss Ratings reaffirmed a “sell (d+)” rating on shares of UnitedHealth Group in a report on Saturday, September 27th. Finally, Royal Bank Of Canada decreased their price objective on shares of UnitedHealth Group from $355.00 to $286.00 and set an “outperform” rating for the company in a research note on Wednesday, July 30th. Sixteen analysts have rated the stock with a Buy rating, six have given a Hold rating and four have assigned a Sell rating to the stock. Based on data from MarketBeat.com, the stock currently has a consensus rating of “Hold” and an average target price of $365.00.

UnitedHealth Group Stock Up 1.4%

UNH stock opened at $363.95 on Wednesday. The company has a market capitalization of $329.62 billion, a price-to-earnings ratio of 15.77, a PEG ratio of 2.33 and a beta of 0.47. UnitedHealth Group Incorporated has a fifty-two week low of $234.60 and a fifty-two week high of $630.73. The company has a debt-to-equity ratio of 0.73, a quick ratio of 0.85 and a current ratio of 0.85. The stock has a fifty day moving average of $311.44 and a 200-day moving average of $352.42.

UnitedHealth Group (NYSE:UNH) last announced its quarterly earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business had revenue of $111.62 billion for the quarter, compared to analysts’ expectations of $111.75 billion. During the same quarter in the previous year, the company posted $6.80 earnings per share. The business’s quarterly revenue was up 12.9% compared to the same quarter last year. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. As a group, equities research analysts predict that UnitedHealth Group Incorporated will post 29.54 earnings per share for the current year.

UnitedHealth Group Dividend Announcement

The business also recently announced a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a $2.21 dividend. The ex-dividend date was Monday, September 15th. This represents a $8.84 annualized dividend and a yield of 2.4%. UnitedHealth Group’s dividend payout ratio (DPR) is currently 38.30%.

About UnitedHealth Group

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.